purpose review experience helium ion therapy therapeutic alternative enucleation uveal melanoma particularly respect survival local control morbidity methods materials NUMBER patients uveal melanoma treated helium ion rt nonrandomized study undertaken doses progressively reduced NUMBER gye fractions NUMBER gye fractions given days mean NUMBER days results local control achieved NUMBER patients difference rate local control seen NUMBER NUMBER NUMBER NUMBER gye fractions lowest dose level NUMBER gye fractions local control rate fell NUMBER NUMBER patients NUMBER local regrowth eye requiring enucleation NUMBER patients laser NUMBER patient reirradiation NUMBER patients time appearance local regrowth ranged NUMBER months NUMBER years posttreatment NUMBER occurring NUMBER years NUMBER patients NUMBER alive NUMBER NUMBER median follow patients NUMBER years range years km survival NUMBER NUMBER years NUMBER NUMBER years NUMBER NUMBER years posttreatment patients tumors involving ciliary body km survival NUMBER results patients tumors involved ciliary body poor km survival NUMBER percent patients tumors NUMBER mm fovea optic nerve initial ultrasound height NUMBER mm retained vision better posttreatment patients tumors larger NUMBER mm thickness tumors lying close optic nerve fovea reduced chance retaining useful vision enucleation rate NUMBER NUMBER local failure NUMBER complications helium rt particularly neovascular glaucoma occurred NUMBER patients conclusions local control retention eye excellent complications therapy reduce vision eye preservation percent patients manifested distant metastases NUMBER NUMBER months posttreatment mean NUMBER months median NUMBER months distant metastases appear caused persistent tumor eye risk metastases high patients tumors greater NUMBER mm initial ultrasound height NUMBER anterior tumors involving ciliary body NUMBER local failure NUMBER patients tumors involving ciliary body initial dimensions NUMBER mm NUMBER chance death melanoma search effective adjuvant therapy needed patients high risk metastases large tumors ciliary body involved local regrowth eye long term NUMBER NUMBER dose searching NUMBER NUMBER NUMBER NUMBER kaplan maier NUMBER year NUMBER year seventy late appearing NUMBER NUMBER